肝脏剪切波弹性成像联合GGT/PLT比值诊断慢性乙型肝炎患者肝纤维化价值研究*

doi:10.3969/j.issn.1672-5069.2023.03.008

摘要/Abstract

摘要： 目的探讨肝脏超声剪切波弹性成像(SWE)联合γ-谷氨酰转肽酶(GGT)/血小板(PLT)比值(GPR)诊断慢性乙型肝炎(CHB)患者肝纤维化的效能。方法 2021年2月～2022年12月我院收治的CHB患者130例,均接受肝穿刺活组织检查。使用超声检测肝脏杨氏模量值,常规检测血清GGT和全血PLT计数,计算GGT/PLT比值。采用Kappa检验分析各诊断方法与病理学诊断CHB患者肝纤维化结果的一致性,应用受试者工作特征曲线下面积(AUROCs)评估各指标诊断CHB患者肝纤维化的效能。结果在130例CHB患者中,经肝组织学检查,诊断F0、F1、F2、F3和F4期肝纤维化分别93例、14例、8例、12例和3例,其中显著性肝纤维化23例;F3期肝纤维化患者GGT/PLT比值和杨氏模量值分别为0.5(0.4,0.7)和(10.4±1.5)kPa,F2期分别为0.4(0.3,0.6)和(8.9±1.6)kPa,均显著大于F1期[分别为0.4(0.3,0.5)和(7.3±1.2)kPa,P<0.05];经AUROCs分析结果显示,GGT/PLT比值、杨氏模量值或两者联合诊断CHB患者肝纤维化与组织病理学诊断结果一致性较好(Kappa=0.42,Kappa=0.50和Kappa=0.63,P＜0.05);应用GGT/PLT比值联合杨氏模量值诊断CHB患者显著性肝纤维化的AUC为0.83(95%CI:0.76～0.94),其灵敏度和特异度分别为83.8%和83.9%,显著优于两指标单一诊断(P＜0.05)。结论应用GGT/PLT比值和SWE检测辅助诊断CHB患者肝纤维化有一定的临床价值,值得进一步探讨。

关键词: 慢性乙型肝炎, 肝纤维化, 肝脏超声剪切波弹性成像, γ-谷氨酰转肽酶/血小板比值, 诊断

Abstract: Objective The aim of this study was to investigate the diagnostic efficacy of significant liver fibrosis (SLF) by two-dimensional shear wave elastography (SWE) andγ-glutamyltransferase (GGT)/platelet (PLT) ratio (GPR) in patients with chronic hepatitis B (CHB). Methods 130 patients with CHB were encountered in our hospital between February 2021 and December 2022, and all underwent liver biopsy. The Young's modulus of livers was detected by SWE of ultrasonography, serum GGT levels and whole blood PLT counts were detected routinely, and the GPR was calculated. The consistency between the Young's modulus and GPR and the pathological diagnosis was evaluated by Kappa test, and the diagnostic efficacy was assessed by the area under the receiver operating characteristic curve (AUROCs). Results Out of the 130 patients with CHB, the liver histopathological examination showed F0, F1, F2, F3 and F4 in 93 cases, 14 cases, 8 cases, 12 cases and 3 cases, with SLF in 23 cases; the GPR and the Young's modulus in patients with stage F3 liver fibrosis were 0.5(0.4, 0.7) and (10.4±1.5)kPa, and in patients with F2 were 0.4(0.3, 0.6) and (8.9±1.6)kPa, all significantly greater than [0.4(0.3, 0.5) and (7.3±1.2)kPa, respectively, P<0.05] in patients with F1; the AUROCs analysis showed the good consistency between the Young's modulus, GPR or the combination of the two parameters, and the pathological diagnosis (Kappa=0.42, Kappa=0.50 and Kappa=0.63, respectively, P＜0.05); the AUC was 0.83 (95%CI:0.76-0.94), with the sensitivity and the specificity of 83.8% and 83.9% by the combination of GPR and Young's modulus in predicting SLF in patients with CHB, much superior to that by any one of the two alone(P＜0.05). Conclusion The GPR and the SWE by ultrasonography might be applied to predict the SLF in patients with CHB clinically, and warrants further investigation.

Key words: Hepatitis B, Liver fibrosis, Shear wave elastography, γ- glutamyltransferase / platelet ratio, Diagnosis

赵景, 何秀波, 谌瑾寰. 肝脏剪切波弹性成像联合GGT/PLT比值诊断慢性乙型肝炎患者肝纤维化价值研究^*[J]. 实用肝脏病杂志, 2023, 26(3): 332-335.

Zhao Jing, He Xiubo, Chen Jinhuan. Early diagnosis of significant liver fibrosis by liver shear wave elastography and GGT/PLT ratio in patients with chronic hepatitis B[J]. Journal of Practical Hepatology, 2023, 26(3): 332-335.

参考文献

[1] Tan M, Bhadoria A S, Cui F, et al. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol,2021,6(2):106-119.
[2] Testoni B, Lebosse F, Scholtes C, et al. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients. J Hepatol,2019,70(4):615-625.
[3] Gulbay M, Ciliz D S, Celikbas A K, et al. Intravoxel incoherent motion parameters in the evaluation of chronic hepatitis B virus-induced hepatic injury: fibrosis and capillarity changes. Abdom Radiol (NY),2020,45(8):2345-2357.
[4] Kayadibi H, Yilmaz B, Ozgur Y A, et al. Development and evaluation of a novel noninvasive index for predicting significant fibrosis, advanced fibrosis, and cirrhosis in patients with chronic hepatitis B infection. Eur J Gastroenterol Hepatol,2021,33(1):e121-e130.
[5] 梁程飞,常宇南,彭小蓉,等. 慢性乙型肝炎儿童肝脏病理特征分析及其肝纤维化非侵入性指标探索. 中华肝脏病杂志,2021,29(6):551-557.
[6] Yue W, Li Y, Geng J, et al. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B. Medicine (Baltimore),2019,98(49):180-182.
[7] Dong B, Huang S, Chang J, et al. Comparison of sound touch elastography, sound touch quantify, and 4 serum fibrosis indexes for the diagnosis of liver fibrosis in patients with chronic hepatitis B. Ultrasound Q,2021,37(2):123-128.
[8] Dong B, Lyu G, Chen Y, et al. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis. Expert Rev Gastroenterol Hepatol,2021,15(9):1077-1089.
[9] 中华医学会感染病学分会,中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 实用肝脏病杂志,2020,23(1):9-32.
[10] Zhu Y F, Tan Y F, Xu X, et al. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study. Medicine (Baltimore),2019,98(50):183-189.
[11] 中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版). 中华肝脏病杂志,2019,27(7):494-504.
[12] Sobhy A, Fakhry M M, Aih A H, et al. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus. J Investig Med,2019,67(3):681-685.
[13] Liu X, Li H, Wei L, et al. Optimized cutoffs of gamma-glutamyl transpeptidase-to-platelet ratio, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 scoring systems for exclusion of cirrhosis in patients with chronic hepatitis B. Hepatol Commun,2022,6(7):1664-1672.
[14] Calvopina D A, Lewindon P J, Ramm L E, et al. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric cystic fibrosis. J Cyst Fibros,2022,21(2):236-242.
[15] Aksakal M, Oktar S O, Sendur H N, et al. Diagnostic performance of 2D shear wave elastography in predicting liver fibrosis in patients with chronic hepatitis B and C: a histopathological correlation study. Abdom Radiol (NY),2021,46(7):3238-3244.
[16] Sahin T, Serin A, Emek E, et al. Effectiveness of noninvasive fibrosis markers for the prediction of hepatocellular carcinoma in chronic hepatitis B and chronic hepatitis B+D induced cirrhosis. Transplant Proc,2019,51(7):2397-2402.
[17] Jin K, Wang H, Zeng M, et al. A comparative study of MR extracellular volume fraction measurement and two-dimensional shear-wave elastography in assessment of liver fibrosis with chronic hepatitis B. Abdom Radiol (NY),2019,44(4):1407-1414.
[18] Baldea V, Sporea I, Tudor A, et al. Virtual touch quantification using acoustic radiation force impulse imaging technology versus transient elastography for the noninvasive assessment of liver fibrosis in patients with chronic hepatitis B or C using liver biopsy as the gold standard. J Gastrointestin Liver Dis,2020,29(2):181-190.
[19] Kim M N, Lee J H, Chon Y E, et al. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy. Eur J Gastroenterol Hepatol,2020,32(3):433-439.
[20] Liu J, Li Y, Yang X, et al. Comparison of two-dimensional shear wave elastography with nine serum fibrosis indices to assess liver fibrosis in patients with chronic hepatitis B: a prospective cohort study. Ultraschall Med,2019,40(2):237-246.

肝脏剪切波弹性成像联合GGT/PLT比值诊断慢性乙型肝炎患者肝纤维化价值研究^*

Early diagnosis of significant liver fibrosis by liver shear wave elastography and GGT/PLT ratio in patients with chronic hepatitis B

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陶贞贞, 王永莉, 孙红艳, 王慧芬. 二维剪切波弹性成像诊断慢性乙型肝炎患者肝纤维化价值研究^*[J]. 实用肝脏病杂志, 2023, 26(3): 328-331.
[2]	张丹蕾, 徐静. 艾米替诺福韦治疗慢性乙型肝炎患者早期疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(3): 336-339.
[3]	郭晓玲, 张耀武, 李梦桃, 张辉. 恩替卡韦联合肝爽颗粒治疗慢性乙型肝炎患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(3): 340-343.
[4]	赵玲玲, 王贝贝, 姚勇利, 郑有花, 李亚楠. T2DM合并非酒精性脂肪性肝病伴进展性肝纤维化患者血清抵抗素和TyG指数变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(3): 356-359.
[5]	朱琳, 陈洋, 杨青, 刘俊启. 超声弹性成像评估自身免疫性肝炎患者肝纤维化分期价值分析^*[J]. 实用肝脏病杂志, 2023, 26(3): 360-363.
[6]	孙璀, 曹琳琳, 刘俊. 不同肝病患者血清自身抗体谱阳性率调查^*[J]. 实用肝脏病杂志, 2023, 26(3): 368-371.
[7]	刘玲玉, 王韦, 汤佳美. 超声三维斑点追踪技术早期诊断失代偿期肝硬化患者心肌损害应用价值分析^*[J]. 实用肝脏病杂志, 2023, 26(3): 400-403.
[8]	石磊, 安梓铭, 冯琴. 联合检测血清AFP、AFP-L3%和PIVKA-II水平早期诊断和判断原发性肝癌患者预后临床价值探讨^*[J]. 实用肝脏病杂志, 2023, 26(3): 404-407.
[9]	陈启全, 李晓婷, 杨勋祎, 王翔. 超声造影、剪切波弹性成像和增强CT检查诊断肝细胞癌价值分析^*[J]. 实用肝脏病杂志, 2023, 26(3): 408-411.
[10]	林永祝, 史红媛, 穆西虎. 双源CT肝动脉三期扫描和增强灌注扫描诊断肝硬化背景下小原发性肝癌价值研究^*[J]. 实用肝脏病杂志, 2023, 26(3): 412-415.
[11]	段海珊, 蒋黎, 田青青, 孔令军, 游忠岚, 何小勤. 原发性肝癌和肝血管瘤患者超声造影表现特点比较^*[J]. 实用肝脏病杂志, 2023, 26(3): 420-423.
[12]	苏佩华, 宋枚芳, 赵彩彦. 慢性乙型肝炎合并非酒精性脂肪性肝病与肝细胞癌[J]. 实用肝脏病杂志, 2023, 26(3): 445-448.
[13]	方慧晶, 朱传龙, 章莉莉. 宿主靶向抗乙型肝炎病毒治疗策略研究新进展^*[J]. 实用肝脏病杂志, 2023, 26(3): 449-452.
[14]	白婷婷, 刘钰懿, 陈东风. 肝脏血管性疾病诊断与鉴别诊断[J]. 实用肝脏病杂志, 2023, 26(2): 153-155.
[15]	尹雯, 鲁科翔, 王雪, 王彩艳. 恩替卡韦联合苦参素治疗HBeAg阳性慢性乙型肝炎患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(2): 173-176.